A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy
A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy
Active, not recruiting · NCT06642909 · Registry updated 2025-11-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy | Primary Membranous Nephropathy | Active, not recruiting | Phase 2 | 2025-11-20 | NCT06642909 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BioRay Pharmaceutical Co., Ltd. | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhongshan Hospital Fudan University | Shanghai | China | 13 |